Literature DB >> 26679882

DISC (Degenerate-disc Infection Study With Contaminant Control): Pilot Study of Australian Cohort of Patients Without the Contaminant Control.

Prashanth J Rao1,2,3, Kevin Phan1,2,3, Rajesh Reddy1,2, Daniel B Scherman3, Peter Taylor1, Ralph J Mobbs1,2,3.   

Abstract

STUDY
DESIGN: Prospective cohort study.
OBJECTIVE: To evaluate if degenerative disc-related back or neck pain and/or radicular symptoms are caused by infection with low virulent bacterial organisms. SUMMARY OF BACKGROUND DATA: The potential relationship between disc infection and disc degeneration-related symptoms remains controversial, with contradictory evidence available in the literature. Several studies have demonstrated the presence of infected extruded nucleus tissue from first-time disc herniation, implicating the role of disc microbial infection in disc degeneration. The current study is a pilot study evaluating if high infection rates are prevalent in the Australian degenerate disc cohort.
METHODS: Institutional ethics approval was obtained (HREC 13/218). The pilot project was a single spine center prospective cohort of patients undergoing spine surgery for degenerate disc disease. In each case, disc material was obtained and prolonged aerobic and anaerobic cultures performed as per methods used by Stirling et al.
RESULTS: To date, a total of 168 patients have been enrolled, with male: female = 1:1. Surgical caseload includes 17.9% anterior cervical fusion, 35.0% anterior lumbar fusion, 40.7% lumbar discectomy, and 5.7% posterior lumbar fusions; 34.1% patients presented with neck pain, 31.6% with arm pain, 59.3% with leg pain, and 64.2% with back pain, and 20.2% of the patients received transforaminal or epidural or facet joint injections prior to surgery. In this pilot study, 19.6% were culture positive, with P. acnes predominant in 50%. Disc-only cultures were positive in 27.8% of lumbar cases and 18.5% of cervical cases, with predominant organisms being P. acnes.
CONCLUSION: Similar to the infection rates from previous studies, this Australian cohort had 19.6% infection rates when disc-only cultures are performed. P. acnes is the predominant organism followed by Streptococcus sp. It is imperative to perform contaminant controls as such high infection with skin bugs is a significant finding. LEVEL OF EVIDENCE: 4.

Entities:  

Mesh:

Year:  2016        PMID: 26679882     DOI: 10.1097/BRS.0000000000001404

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  11 in total

1.  Association between chronic inflammation and latent infection of Propionibacterium acnes in non-pyogenic degenerated intervertebral discs: a pilot study.

Authors:  Ye Yuan; Yong Chen; Zezhu Zhou; Yucheng Jiao; Changwei Li; Yuehuan Zheng; Yazhou Lin; Jiaqi Xiao; Zhe Chen; Peng Cao
Journal:  Eur Spine J       Date:  2017-10-31       Impact factor: 3.134

2.  Low virulence bacterial infections in cervical intervertebral discs: a prospective case series.

Authors:  Yilei Chen; Xianjun Wang; Xuyang Zhang; Hong Ren; Bao Huang; Jian Chen; Junhui Liu; Zhi Shan; Zhihai Zhu; Fengdong Zhao
Journal:  Eur Spine J       Date:  2018-04-19       Impact factor: 3.134

3.  Different responses of cervical intervertebral disc caused by low and high virulence bacterial infection: a comparative study in rats.

Authors:  Jie Li; Yilei Chen; Hao Wu; Zhi Shan; Dikai Bei; Kaifeng Gan; Junhui Liu; Xuyang Zhang; Binhui Chen; Jian Chen; Feng-Dong Zhao
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Answer to the Letter to the Editor of Manu N. Capoor et al. concerning "Low virulence bacterial infections in cervical intervertebral discs: a prospective case series" by Chen Y, Wang X, Zhang X, et al. (Eur Spine J; 2018: doi: 10.1007/s00586-018-5582-4).

Authors:  Yilei Chen; Xianjun Wang; Xuyang Zhang; Zhihai Zhu; Fengdong Zhao
Journal:  Eur Spine J       Date:  2018-06-29       Impact factor: 3.134

5.  Frequency and characteristics of bacterial and viral low-grade infections of the intervertebral discs: a prospective, observational study.

Authors:  Wolfgang Senker; Stefan Aspalter; Christian Radl; Josef Pichler; Stefan Doppler; Serge Weis; Christine Webersinke; Helga Wagner; Philipp Hermann; Martin Aichholzer; Kathrin Aufschnaiter-Hießböck; Wolfgang Thomae; Nico Stroh; Thomas Hauser; Andreas Gruber
Journal:  J Orthop Traumatol       Date:  2022-03-18

6.  Histological Identification of Propionibacterium acnes in Nonpyogenic Degenerated Intervertebral Discs.

Authors:  Ye Yuan; Zezhu Zhou; Yucheng Jiao; Changwei Li; Yuehuan Zheng; Yazhou Lin; Jiaqi Xiao; Zhe Chen; Peng Cao
Journal:  Biomed Res Int       Date:  2017-03-19       Impact factor: 3.411

7.  Propionibacterium acnes induces intervertebral disc degeneration by promoting nucleus pulposus cell apoptosis via the TLR2/JNK/mitochondrial-mediated pathway.

Authors:  Yazhou Lin; Yucheng Jiao; Ye Yuan; Zezhu Zhou; Yuehuan Zheng; Jiaqi Xiao; Changwei Li; Zhe Chen; Peng Cao
Journal:  Emerg Microbes Infect       Date:  2018-01-10       Impact factor: 7.163

8.  Propionibacterium acnes Induces Intervertebral Disc Degeneration by Promoting iNOS/NO and COX-2/PGE2 Activation via the ROS-Dependent NF-κB Pathway.

Authors:  Yazhou Lin; Guoqing Tang; Yucheng Jiao; Ye Yuan; Yuehuan Zheng; Yong Chen; Jiaqi Xiao; Changwei Li; Zhe Chen; Peng Cao
Journal:  Oxid Med Cell Longev       Date:  2018-08-19       Impact factor: 6.543

9.  Microbicidal Phagocytosis of Nucleus Pulposus Cells Against Staphylococcus aureus via the TLR2/MAPKs Signaling Pathway.

Authors:  Yazhou Lin; Hui Cong; Kewei Liu; Yucheng Jiao; Ye Yuan; Guoqing Tang; Yong Chen; Yuehuan Zheng; Jiaqi Xiao; Changwei Li; Zhe Chen; Peng Cao
Journal:  Front Immunol       Date:  2019-05-22       Impact factor: 7.561

10.  Effectiveness of intradiscal injection of radiopaque gelified ethanol (DiscoGel®) versus percutaneous laser disc decompression in patients with chronic radicular low back pain.

Authors:  Masoud Hashemi; Payman Dadkhah; Mehrdad Taheri; Pegah Katibeh; Saman Asadi
Journal:  Korean J Pain       Date:  2020-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.